Although WHO reports that additional cases are expected to occur, the risk for widespread transmission is considered to be low, and currently there are no travel or trade restrictions to Liberia. The agency is advising countries in West Africa that are endemic for Lassa fever to strengthen their surveillance systems. To date, Liberia has identified 134 contacts who completed a 21-day follow-up period and 17 who are currently being monitored.
Lassa fever is primarily transmitted to humans through exposure to rodent urine or feces, according to WHO. Symptoms may include headache, sore throat, muscle pain, chest pain, nausea, vomiting, diarrhea, cough and abdominal pain. In severe cases, facial swelling, fluid in the lungs, low blood pressure and bleeding from the mouth, nose, vagina or gastrointestinal tract may occur. The disease also is associated with hearing loss in 25% of survivors.
As the symptoms of Lassa fever vary, it is often difficult to diagnose the disease, WHO reported. It also is difficult to distinguish from Ebola virus disease and other hemorrhagic fevers.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.